Back to Feed
Fintech– 0
MapLight Therapeutics GAAP EPS Reported
Seekingalpha·
MapLight Therapeutics, Inc. has reported its Generally Accepted Accounting Principles (GAAP) earnings per share (EPS) as -$2.47. This figure reflects the company's financial performance during the specified reporting period. Further details regarding revenue, net income, and operational expenses would be necessary to provide a comprehensive analysis of the company's financial health and future outlook.
Tags
earnings
healthcare
Original Source
Seekingalpha — seekingalpha.com